New analogues of the venerable antimalarial drug primaquine have been synth
esized and bioassayed in vivo against Pneumocystis carinii, a life-threaten
ing infection common among immunosuppressed patients. Two of these new comp
ounds are significantly more active than primaquine itself, and provide new
information for future drug design and development in this area. (C) 2000
Elsevier Science Ltd. All rights reserved.